By G HossainPosted on June 2, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Blueprint has a next-generation systemic mastocytosis treatment, called elenestinib, that Sanofi CEO Paul Hudson told analysts provides an “opportunity to grow through the ‘30s.” Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio Post navigation Keros Cuts 45% of Workforce Along With Pulmonary Hypertension DrugAmid Rough Waters, Regeneron Puts Nearly $2B on the Line For Chinese Obesity Drug